Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment

Wednesday, May 25, 2011 General News
Email Print This Page Comment
Font : A-A+

CEN-209 shows potential to enable successful treatment of tumors that are resistant to standard treatments like radiotherapy and chemotherapy

FOR INFORMATION CONTACT:

Centella/Varian Medical Systems

Auckland UniServices, Ltd

Meryl Ginsberg, 650-424-6444

Josie Heap, +64 9 923 4216

meryl.ginsberg@varian.com

j.heap@auckland.ac.nz



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook